Affilogic
Develops Nanofitin-based therapeutics and custom binding proteins for pharmaceutical and biotech partners
Highlights
- New on EvolcAdded 2026-10-30
About Affilogic
Affilogic discovers and develops Nanofitin-based therapeutics for applications including brain delivery, antiviral inhalation, oral gastrointestinal treatments and drug conjugates. It also provides custom Nanofitin discovery, development and combination against partner-nominated targets.
The company conducts internal research and development programs and collaborates internationally with pharmaceutical and biotechnology companies. It is based in Nantes, France, where it established larger facilities in 2022 for discovery and early development, including non-GMP production.
Product: Nanofitin-based therapeutic programs and custom discovery, development and combination of binding proteins for partner targets.
Jobs at Affilogic
More biotech & pharma companies
Affinisep
Sample preparation kits and SPE cartridges for analytical labs in proteomics, metabolomics, and water analysisNew on EvolcAfyia Diagnostics
PCR diagnostic kits for infectious disease testing by clinical and research laboratoriesYoung companyNew on EvolcAlliance Bio Expertise
Automated microbiology lab equipment and culture media for food, cosmetics, pharma and clinical labsNew on EvolcAnalysis Expertise
Forensic toxicology and genetic testing for courts and law enforcement agenciesYoung companyNew on EvolcAntabio
Clinical-stage biopharma developing antibiotics for multidrug-resistant hospital infections in wards and ICUsNew on EvolcApmonia Therapeutics
Develops peptide-based cancer therapies targeting the tumor microenvironment for patients with cancerNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- WordPress
- jQuery